| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14656566.4.4.445 |
| P698 | PubMed publication ID | 12667108 |
| P2093 | author name string | John J Craig | |
| James I Morrow | |||
| P2860 | cites work | Cardiac defects in children of mothers receiving anticonvulsant therapy during pregnancy | Q28333680 |
| Additional educational needs in children born to mothers with epilepsy | Q28345141 | ||
| Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate | Q28371105 | ||
| Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy | Q28379440 | ||
| Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation | Q29615365 | ||
| Best practice guidelines for the management of women with epilepsy. The Women with Epilepsy Guidelines Development Group | Q33714858 | ||
| Folic acid antagonists during pregnancy and the risk of birth defects. | Q33926560 | ||
| On the association between valproate and polycystic ovary syndrome | Q34301379 | ||
| How common is catamenial epilepsy? | Q34357621 | ||
| Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth | Q35439268 | ||
| Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 1: Animal studies | Q37025267 | ||
| Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 2: Human studies | Q37025275 | ||
| Minor anomalies in offspring of epileptic mothers | Q39296948 | ||
| The fetal hydantoin syndrome | Q39338123 | ||
| Evidence for multi-site closure of the neural tube in humans | Q40793454 | ||
| A possible primidone embryopathy | Q41635701 | ||
| The teratogenicity of anticonvulsant drugs | Q41923758 | ||
| Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications | Q41927333 | ||
| Teratogenic valproic acid concentrations: infusion by implanted minipumps vs conventional injection regimen in the mouse | Q42226002 | ||
| The fetal valproate syndrome | Q42249396 | ||
| Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy | Q42275048 | ||
| Repeated neural tube defects and valproate monotherapy suggest a pharmacogenetic abnormality | Q43650811 | ||
| Intelligence of children of epileptic mothers | Q43680106 | ||
| Lamotrigine plasma levels reduced by oral contraceptives | Q43774655 | ||
| Pattern of malformations in the children of women treated with carbamazepine during pregnancy | Q43779596 | ||
| Enzyme-inducing antiepileptic drugs in pregnancy and the risk of bleeding in the neonate | Q43896010 | ||
| Factors influencing the risk of abnormal pregnancy outcome in epileptic women: a multi-centre prospective study | Q43986196 | ||
| Valproate embryopathy in three sets of siblings: further proof of hereditary susceptibility | Q44115123 | ||
| Topiramate kinetics during delivery, lactation, and in the neonate: preliminary observations | Q44169560 | ||
| Preliminary results on pregnancy outcomes in women using lamotrigine | Q44169564 | ||
| Information recalled by women taking anti-epileptic drugs for epilepsy: a questionnaire study | Q44233538 | ||
| Temporal distribution of seizures in epilepsy | Q44469792 | ||
| Do Anticonvulsants Reduce the Efficacy of Oral Contraceptives? | Q45936837 | ||
| Self-reported sexual function and sexual arousability in women with epilepsy | Q46384317 | ||
| Pregnancies of women with epilepsy: a population-based study in Iceland | Q47634154 | ||
| Obesity and endocrine disorders in women taking valproate for epilepsy. | Q51034614 | ||
| Developmental toxicity studies in mice, rats, and rabbits with the anticonvulsant gabapentin. | Q52213253 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 445-456 | |
| P577 | publication date | 2003-04-01 | |
| P1433 | published in | Expert Opinion on Pharmacotherapy | Q5421212 |
| P1476 | title | Anti-epileptic drugs in pregnancy: current safety and other issues | |
| P478 | volume | 4 |
| Q36511300 | Birth defects and epilepsy medication |
| Q36263826 | Effect of anti-epileptic drugs in pregnancy and teratogenesis |
| Q31046235 | Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry. |
| Q36142531 | Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register |
| Q46648132 | Maternal valproate dosage and foetal malformations |
| Q46908652 | The Australian Register of Antiepileptic Drugs in Pregnancy: the first 1002 pregnancies |
| Q36425094 | The course and outcome of pregnancy and neonatal situation in epileptic women |
| Q36603158 | Therapeutic monitoring of antiepileptic drugs during pregnancy and in the postpartum period: is it useful? |
Search more.